Pharmacogenomics: current status and future perspectives

M Pirmohamed - Nature Reviews Genetics, 2023 - nature.com
Inter-individual variability in drug response, be it efficacy or safety, is common and likely to
become an increasing problem globally given the growing elderly population requiring …

Biological and functional multimorbidity—from mechanisms to management

C Langenberg, AD Hingorani, CJM Whitty - Nature Medicine, 2023 - nature.com
Globally, the number of people with multiple co-occurring diseases will increase
substantially over the coming decades, with important consequences for patients, carers …

The potential of metabolomics in biomedical applications

V Gonzalez-Covarrubias, E Martínez-Martínez… - Metabolites, 2022 - mdpi.com
The metabolome offers a dynamic, comprehensive, and precise picture of the phenotype.
Current high-throughput technologies have allowed the discovery of relevant metabolites …

Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM): cluster randomised controlled trial

MR Blum, BTGM Sallevelt, A Spinewine, D O'Mahony… - bmj, 2021 - bmj.com
Objective To examine the effect of optimising drug treatment on drug related hospital
admissions in older adults with multimorbidity and polypharmacy admitted to hospital …

A multimodal deep learning framework for predicting drug–drug interaction events

Y Deng, X Xu, Y Qiu, J **a, W Zhang, S Liu - Bioinformatics, 2020 - academic.oup.com
Abstract Motivation Drug–drug interactions (DDIs) are one of the major concerns in
pharmaceutical research. Many machine learning based methods have been proposed for …

A gentle introduction to reinforcement learning and its application in different fields

M Naeem, STH Rizvi, A Coronato - IEEE access, 2020 - ieeexplore.ieee.org
Due to the recent progress in Deep Neural Networks, Reinforcement Learning (RL) has
become one of the most important and useful technology. It is a learning method where a …

Economic analysis of the prevalence and clinical and economic burden of medication error in England

RA Elliott, E Camacho, D Jankovic… - BMJ Quality & …, 2021 - qualitysafety.bmj.com
Objectives To provide national estimates of the number and clinical and economic burden of
medication errors in the National Health Service (NHS) in England. Methods We used UK …

A Review of the Important Role of CYP2D6 in Pharmacogenomics

C Taylor, I Crosby, V Yip, P Maguire, M Pirmohamed… - Genes, 2020 - mdpi.com
Cytochrome P450 2D6 (CYP2D6) is a critical pharmacogene involved in the metabolism of~
20% of commonly used drugs across a broad spectrum of medical disciplines including …

Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail

P Pound, M Ritskes-Hoitinga - Journal of translational medicine, 2018 - Springer
Background The pharmaceutical industry is in the midst of a productivity crisis and rates of
translation from bench to bedside are dismal. Patients are being let down by the current …